(NASDAQ: HOOK) Hookipa Pharma's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 14.13%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.95%.
Hookipa Pharma's earnings in 2025 is -$43,371,000.On average, 1 Wall Street analyst forecast HOOK's earnings for 2025 to be -$31,341,801, with the lowest HOOK earnings forecast at -$31,341,801, and the highest HOOK earnings forecast at -$31,341,801. On average, 1 Wall Street analyst forecast HOOK's earnings for 2026 to be -$18,805,081, with the lowest HOOK earnings forecast at -$18,805,081, and the highest HOOK earnings forecast at -$18,805,081.
In 2027, HOOK is forecast to generate -$15,068,174 in earnings, with the lowest earnings forecast at -$15,068,174 and the highest earnings forecast at -$15,068,174.